CVS Health Change in Accounts Payable 2010-2025 | CVS

CVS Health annual/quarterly change in accounts payable history and growth rate from 2010 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.
  • CVS Health change in accounts payable for the quarter ending June 30, 2025 was $2.619B, a 285.74% decline year-over-year.
  • CVS Health change in accounts payable for the twelve months ending June 30, 2025 was $8.314B, a 82.48% increase year-over-year.
  • CVS Health annual change in accounts payable for 2024 was $2.335B, a 35.46% decline from 2023.
  • CVS Health annual change in accounts payable for 2023 was $3.618B, a 15.07% decline from 2022.
  • CVS Health annual change in accounts payable for 2022 was $4.26B, a 47% increase from 2021.
CVS Health Annual Change in Accounts Payable
(Millions of US $)
2024 $2,335
2023 $3,618
2022 $4,260
2021 $2,898
2020 $2,769
2019 $3,550
2018 $2,329
2017 $1,710
2016 $2,189
2015 $2,834
2014 $1,742
2013 $1,024
2012 $1,147
2011 $1,128
2010 $-40
2009 $4
Sector Industry Market Cap Revenue
Medical Medical Services $87.007B $372.809B
CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $151.037B 28.01
Elevance Health (ELV) United States $69.708B 9.38
Cencora (COR) United States $56.771B 18.90
DiDi Global (DIDIY) China $25.839B 27.45
Labcorp Holdings (LH) United States $22.469B 17.86
Natera (NTRA) United States $22.374B 0.00
BioMerieux (BMXMF) France $17.238B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $15.627B 0.00
ICON (ICLR) Ireland $14.200B 13.66
CochLear (CHEOY) Australia $13.374B 0.00
Medpace Holdings (MEDP) United States $12.862B 34.04
Solventum (SOLV) United States $12.383B 12.78
Viatris (VTRS) United States $12.370B 4.40
Revvity (RVTY) United States $10.537B 18.56
Caris Life Sciences,�Inc (CAI) United States $10.265B 0.00
Sonic Healthcare (SKHHY) Australia $9.104B 0.00
Avantor (AVTR) United States $8.815B 12.93
HealthEquity (HQY) United States $7.773B 34.05
Charles River Laboratories (CRL) United States $7.711B 14.63
Bausch + Lomb (BLCO) Canada $5.151B 34.64
Sotera Health (SHC) United States $4.471B 24.98
BrightSpring Health Services (BTSG) United States $3.975B 30.32
Amplifon S.p.A (AMFPF) Italy $3.937B 21.83
GeneDx Holdings (WGS) United States $3.630B 83.13
Alignment Healthcare (ALHC) United States $2.980B 0.00
Concentras Parent (CON) United States $2.979B 18.89
Surgery Partners (SGRY) United States $2.923B 36.77
Organon (OGN) United States $2.454B 2.67
Premier (PINC) United States $2.054B 15.59
Progyny (PGNY) United States $2.012B 42.54
Ardent Health (ARDT) United States $1.786B 6.89
PACS (PACS) United States $1.753B 0.00
Pediatrix Medical (MD) United States $1.397B 9.33
Teladoc Health (TDOC) United States $1.329B 0.00
GoodRx Holdings (GDRX) United States $1.296B 21.94
Omada Health (OMDA) $1.182B 0.00
Establishment Labs Holdings (ESTA) $1.110B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.965B 0.00
Embecta (EMBC) United States $0.801B 4.69
AMN Healthcare Services Inc (AMN) United States $0.725B 8.97
CareDx (CDNA) United States $0.630B 11.61
Performant Healthcare (PHLT) United States $0.601B 0.00
QDM (QDMI) Hong Kong, SAR China $0.525B 90.00
Nutex Health (NUTX) United States $0.516B 7.81
Sonida Senior Living (SNDA) United States $0.476B 0.00
Auna S.A (AUNA) Luxembourg $0.467B 10.52
InnovAge Holding (INNV) United States $0.463B 0.00
SBC Medicals (SBC) United States $0.462B 10.14
Agilon Health (AGL) United States $0.460B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.414B 0.00
Enhabit (EHAB) United States $0.383B 25.20
So-Young (SY) China $0.379B 0.00
Oncology Institute (TOI) United States $0.336B 0.00
LifeMD (LFMD) United States $0.305B 0.00
Beauty Health (SKIN) United States $0.276B 0.00
Shoulder Innovations (SI) United States $0.215B 0.00
DocGo (DCGO) United States $0.158B 0.00
Ascend Wellness Holdings (AAWH) United States $0.133B 0.00
KindlyMD (NAKA) United States $0.103B 0.00
Sera Prognostics (SERA) United States $0.085B 0.00
NeueHealth (NEUE) United States $0.059B 0.00
Biodesix (BDSX) United States $0.058B 0.00
IceCure Medical (ICCM) Israel $0.053B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.041B 0.00
Basel Medical Group (BMGL) Singapore $0.036B 0.00
ModivCare (MODV) United States $0.034B 0.00
SeaStar Medical Holding (ICU) United States $0.022B 0.00
OSR Holdings (OSRH) United States $0.010B 0.00
Intelligent Bio Solutions (INBS) United States $0.010B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.010B 0.00
XWELL (XWEL) United States $0.007B 0.00
Aclarion (ACON) United States $0.004B 0.00
Pheton Holdings (PTHL) China $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
INVO Fertility (IVF) United States $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00